<?xml version="1.0" encoding="utf-8"?>
	<vdex xmlns="http://www.imsglobal.org/xsd/imsvdex_v1p0"  orderSignificant="false" language="es">
	<vocabIdentifier>http://vocabularios.saij.gob.ar/vuce/</vocabIdentifier><term><termIdentifier>http://vocabularios.saij.gob.ar/vuce/skos/13199</termIdentifier><caption>Basiliximab; etanercept; gemtuzumab       ozogamicin; oprelvekin</caption></term>  <relationship>      <sourceTerm>http://vocabularios.saij.gob.ar/vuce/skos/13199</sourceTerm>      <targetTerm vocabIdentifier="http://vocabularios.saij.gob.ar/vuce/skos/13198">Basiliximab (DCI); bevacizumab (DCI); daclizumab (DCI); etanercept (DCI); gemtuzumab ozogamicin (DCI); oprelvekin (DCI); rituximab (DCI); trastuzumab (DCI)</targetTerm>      <relationshipType source="http://www.imsglobal.org/vocabularies/iso2788_relations.xml">BT</relationshipType>  </relationship></vdex>